Intellectual Property

  • May 29, 2025

    AstraZeneca Inks $51.4M Settlement In Pay-For-Delay Case

    AstraZeneca Pharmaceuticals LP and Handa Pharmaceuticals LLC have agreed to shell out a combined $51.4 million to put to rest allegations AstraZeneca paid off generic-drug makers, including Handa, to protect its brand antipsychotic drug Seroquel XR, according to a filing Thursday in Delaware federal court.

  • May 29, 2025

    Samsung Ends Smartwatch IP Fight With Researchers

    Samsung asked a Texas federal judge to permanently dismiss its patent dispute with a group of academic research institutions over claims that the company's Galaxy smartwatches rely on their algorithms to detect irregular heartbeats and measure other physiological health markers, according to a joint motion filed Wednesday.

  • May 29, 2025

    Judge Finds Epic Verdict Means One Patent Claim Invalid

    A Washington federal judge has found that part of a jury's decision clearing Epic Games Inc. of patent infringement through its Fortnite game platform meant that one of the claims in the patent wasn't patent eligible.

  • May 29, 2025

    ​​​​​​​Netflix's 'Broad' IP Claims Against Broadcom Face Skepticism

    A California federal judge appeared open Thursday to tossing some claims in Netflix's lawsuit accusing Broadcom of ripping off five software patents, repeatedly questioning how Netflix's patents improve technology and calling certain terms "incredibly broad and undefined," while also observing that Netflix's willful infringement claim may amount to "good lawyering."

  • May 29, 2025

    Atty Urges 2nd Circ. To Resurrect Name Feud With Ex-Firm

    A lawyer has asked the Second Circuit to revive claims against his former firm, which he alleges used his name and likeness after he was fired, saying a judge's dismissal of those claims ignored the harm he personally suffered and the requirements of the Lanham Act.

  • May 29, 2025

    Ex-Copyright Chief Wants Fast Ruling In Trump Firing Dispute

    The fired director of the U.S. Copyright Office asked a D.C. federal court Thursday for expedited briefing in her lawsuit challenging her termination by the Trump administration, saying there is "a pressing need" to resolve the matter quickly.

  • May 29, 2025

    Columbia Sportswear Gets Mixed Trade Secrets Ruling

    An Oregon federal judge has partially sided with motions by Columbia Sportswear Co. and a former employee in a case alleging the worker took trade secrets with him when he left the company, but denied the bulk of the requests from all parties seeking to end the suit in their favor.

  • May 29, 2025

    Epic Seeks More Interest On Tata's $140M Punitive Award

    Epic Systems argued Thursday that the Seventh Circuit should order a lower court to recalculate its post-judgment interest on a $140 million punitive damages award against Tata Group because interest should have run from its original 2017 judgment rather than the amended version entered five years later.

  • May 29, 2025

    Ex-USPTO Solicitor Says He's Against Squires Nomination

    A former solicitor for the U.S. Patent and Trademark Office has come out against the nomination of John A. Squires to be the next director of the agency, saying in a letter Thursday that he's concerned about the nominee's desire to make existing patents stronger.

  • May 29, 2025

    Cannabis Package Maker Alleges Trademark Infringement

    A manufacturer of packaging designed for cannabis products alleged in a lawsuit filed Thursday in Oklahoma federal court that a competitor has been infringing its designs and trademarks with knockoff wares.

  • May 29, 2025

    Ex-United Therapeutics Exec Can't Dodge IP Suit

    A former United Therapeutics Corp. executive lost his bid to toss his former employer's suit alleging he used stolen intellectual property to develop a lung disease drug for a competitor, with the North Carolina Business Court ruling that it was too soon to determine if the complaint was untimely.

  • May 29, 2025

    Cochlear Implant Rivals Call Truce Ahead Of UPC Ruling

    Two cochlear implant heavyweights have quietly settled their global patent dispute, with both parties agreeing to dismiss a U.S. appeal on Thursday, bringing an abrupt end to the transatlantic clash.

  • May 29, 2025

    Judge Keeps Betting-Tech Suit On Track As Sanctions Loom

    A Nevada federal judge refused a sportsbook technology company's attempt to stay briefings on a motion for sanctions in its trade secrets suit against a former collaborator, ruling the request lacks sufficient justification.

  • May 29, 2025

    Qualcomm Can't Duck IP Suit Over Snapdragon Processors

    A Texas federal court on Thursday refused to throw out a suit claiming Qualcomm Inc.'s processors infringe a microcontroller patent, finding that it's too early to resolve a dismissal bid and other issues should be worked out first.

  • May 29, 2025

    Apple Says Google Ruling Boosts Appeal Of $300M Verdict

    Apple has told the Federal Circuit that its en banc decision ordering a new damages trial in a separate suit against Google bolsters its own appeal of a $300 million verdict against the tech giant for infringing standard-essential 4G patents owned by Optis.

  • May 29, 2025

    Disney Can't Stop Brazil Court Injunction In IP Row, For Now

    A California federal judge has denied The Walt Disney Co.'s request to block a Brazilian court from taking injunctive action against it in a patent dispute with wireless technology developer InterDigital Inc., saying the entertainment giant has not shown it's likely the Brazilian court will issue a preliminary injunction barring the use of certain video codec technology.

  • May 29, 2025

    Intel Convinces Texas Jury That Fortress Controls VLSI

    A Texas federal jury on Thursday found that Fortress Investment Group controls both VLSI Technology and Finjan Holdings, and a judge will now decide whether that means Intel can escape findings that it infringed VLSI's patents by invoking its license with Finjan.

  • May 29, 2025

    NYT, Amazon Reach Licensing Deal To Use Content For AI

    The New York Times and Amazon have reached a licensing deal for the tech and online retail giant to use the newspaper's editorial content on its artificial intelligence platforms, the companies announced Thursday.

  • May 28, 2025

    Intel Pushes Fortress, VLSI On Financial Control Limits

    Intel Corp. tried to convince an Austin federal jury Wednesday that Fortress Investment Group's power to say "no" when VLSI Technology LLC requests money, among other override authorities, makes clear who has actual control over VLSI's finances, even if that "no" has never been invoked.

  • May 28, 2025

    LADS Copyright Registration Error Revives Suit Against Agilis

    The Eighth Circuit on Wednesday revived LADS Network Solutions Inc.'s lawsuit accusing Agilis Systems LLC of infringing its copyrighted software, saying there is a "genuine dispute" on whether inaccurate information in LADS copyright registration makes it invalid.

  • May 28, 2025

    Judge Says Nokia Might Have License In AT&T 5G Patent Case

    A Texas federal magistrate judge has recommended that the Eastern District of Texas reject an Irish company's effort to defeat Nokia's argument that it couldn't have infringed a telecommunications patent because it has a license from the patent's former owner.

  • May 28, 2025

    5 Federal Circuit Clashes To Watch In June

    The Federal Circuit will hear cases in June that include an attempt to revive and expand a discarded $64 million trade secrets judgment against Goodyear, and a dispute between drugmakers Acorda and Alkermes that asks when licensees who pay royalties on expired patents can get a refund in arbitration.

  • May 28, 2025

    Execs Smuggled Billions In Goods To Skirt Duties, Feds Say

    Two California shipping company executives have been charged with smuggling billions of dollars' worth of goods from the United States into Mexico — avoiding millions of dollars in duties to Mexico — using bogus documents, shell companies, bribes to public officials and kickbacks to drug cartels.

  • May 28, 2025

    Fla. Judge Told Pharma Co. Rival Also Stole Trade Secrets

    A Florida federal judge on Wednesday denied an India-based pharmaceutical company's bid to reject a competitor's defense against a lawsuit alleging trade secrets theft by claiming its accuser is responsible for the same conduct, expressing doubt whether she can rule on such an issue.

  • May 28, 2025

    SG Backs Cox's High Court Bid In Music Copyright Battle

    The U.S. solicitor general has pressed the U.S. Supreme Court to review a Fourth Circuit ruling affirming a contributory copyright infringement verdict against Cox Communications Inc., saying the circuit court's "sweeping view" of that kind of infringement can have downstream effects on internet access.

Expert Analysis

  • Fed. Circ. In Feb.: Lessons On Cases With Many Patent Claims

    Author Photo

    The Federal Circuit's decision in Kroy IP v. Groupon last month establishes that inter partes review petitioners cannot rely on collateral estoppel to invalidate patent claims after challenging a smaller subset, highlighting the benefit that patent owners may gain from seeking patents with many claims, say attorneys at Knobbe Martens.

  • Firms Still Have Lateral Market Advantage, But Risks Persist

    Author Photo

    Partner and associate mobility data from the fourth quarter of 2024 shows that we’re in a new, stable era of lateral hiring where firms have the edge, but leaders should proceed cautiously, looking beyond expected revenue and compensation analyses for potential risks, say Julie Henson and Greg Hamman at Decipher Investigative Intelligence.

  • The New Playbook For Managing Athlete-Controlled IP

    Author Photo

    Comparing Luka Dončić's and Lebron James' approaches to establishing and managing their brands highlights a shift toward athlete-controlled IP and some lessons on how players and teams can collaborate to capitalize on athletes' star power, say attorneys at Debevoise.

  • Opinion

    We Must Allow Judges To Use Their Independent Judgment

    Author Photo

    As two recent cases show, the ability of judges to access their independent judgment crucially enables courts to exercise the discretion needed to reach the right outcome based on the unique facts within the law, says John Siffert at Lankler Siffert & Wohl.

  • The Central Issues Facing Fed. Circ. In Patent Damages Case

    Author Photo

    The en banc Federal Circuit's pending review of EcoFactor v. Google could reshape how expert damages opinions are argued, and could have ripple effects that limit jury awards, say attorneys at McAndrews Held.

  • Series

    Performing Stand-Up Comedy Makes Me A Better Lawyer

    Author Photo

    Whether I’m delivering a punchline on stage or a closing argument in court, balancing stand-up comedy performances and my legal career has demonstrated that the keys to success in both endeavors include reading the room, landing the right timing and making an impact, says attorney Rebecca Palmer.

  • Series

    Adapting To Private Practice: From SEC To BigLaw

    Author Photo

    As I adjusted to the multifaceted workflow of a BigLaw firm after leaving the U.S. Securities and Exchange Commission, working side by side with new colleagues on complex matters proved the fastest way to build a deep rapport and demonstrate my value, says Jennifer Lee at Jenner & Block.

  • China High Court Ruling Could Encourage Antitrust Litigation

    Author Photo

    Practitioners defending U.S. companies in China should take note of a Chinese Supreme Court ruling that plaintiffs can file suits based on either where the alleged action, or where the result of such action, occurred — which will promote civil litigation by minimizing procedural battles over forum selection, says Yang Yang at Leaqual Law Firm.

  • How Fed. Circ. Ruling Complicates Patent Infringement Cases

    Author Photo

    The Federal Circuit's decision last month in Kroy IP Holdings v. Groupon may make defending patent infringement claims more challenging, time-consuming and expensive — but it has also complicated similar patent infringement proceedings involving the same patents and their appeals, say attorneys at Norton Rose.

  • Making The Case For Rest In The Legal Profession

    Author Photo

    For too long, a culture of overwork has plagued the legal profession, but research shows that attorneys need rest to perform optimally and sustainably, so legal organizations and individuals must implement strategies that allow for restoration, says Marissa Alert at MDA Wellness, Carol Ross-Burnett at CRB Global, and Denise Robinson at The Still Center.

  • How Amended Rule 702 Affects Testimony In Patent Litigation

    Author Photo

    In 2023, Federal Rule of Evidence 702 was amended to address the apparent failure of some courts to prevent unreliable expert evidence from reaching a jury, but a statistical analysis of Daubert decisions in 2022 and 2024 shows that courts remain divided about how to apply consistent evidence standards, say attorneys at Perkins Coie.

  • 4 Ways Women Attorneys Can Build A Legal Legacy

    Author Photo

    This Women’s History Month, women attorneys should consider what small, day-to-day actions they can take to help leave a lasting impact for future generations, even if it means mentoring one person or taking 10 minutes to make a plan, says Jackie Prester, a former shareholder at Baker Donelson.

  • Navigating The Growing Thicket Of 'Right To Repair' Laws

    Author Photo

    An emerging patchwork of state laws on the right to repair creates tensions with traditional intellectual property and competition principles, so manufacturers should plan proactively for legal disputes and minimize potential for rival third-party repairs to weaponize state laws, say attorneys at Reed Smith.

  • A Judge's Pointers For Adding Spice To Dry Legal Writing

    Author Photo

    U.S. District Judge Fred Biery shares a few key lessons about how to go against the grain of the legal writing tradition by adding color to bland judicial opinions, such as by telling a human story and injecting literary devices where possible.

  • Preparing For Disruptions To Life Sciences Supply Chains

    Author Photo

    Life sciences companies must assess how new and escalating tariffs — combined with other restrictions on cross-border activity singling out pharmaceutical products and medical devices — will affect supply chains, and they should proactively prepare for antitrust and foreign direct investment regulatory review processes, say attorneys at Weil.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!